Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $30
Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $33 to $30.
Deutsche Bank Maintains Hold on Teladoc Health, Lowers Price Target to $27
Deutsche Bank analyst George Hill maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from $31 to $27.
JP Morgan Maintains Neutral on Teladoc Health, Lowers Price Target to $33
JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $35 to $33.
Why Teladoc Health Shares Are Dropping Today
Teladoc Health, Inc. (NYSE: TDOC) shares are trading lower Thursday after the company issued weak guidance.
eBay, Unity Software, Teladoc Health And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Teladoc Health Sees Q1 Revenue $610M-$625M Vs $642.43M Est; Q1 EPS ($0.55)-($0.45) Vs ($0.41) Est
Financial Outlook
Teladoc Health provides an outlook based on current market conditions and expectations and what we know today. Based on what we know today, we believe our outlook ranges
After-Hours Alert: Why Teladoc Stock Is Diving
Teladoc Health Inc (NYSE: TDOC) shares are trading lower in Tuesday's after-hours session after the company reported
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell
• Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.
Barclays Maintains Equal-Weight on Teladoc Health, Lowers Price Target to $28
Barclays analyst Marc Solecitto maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and lowers the price target from $32 to $28.
There’s No ‘Real’ Competition In The Athleisure Space: Why This Investor Bought Lululemon Stock With Shares Stretched Out
Lululemon Athletica Inc (NASDAQ: LULU) shares are on sale Monday after the company narrowed its holiday quarter outlook. Short Hills Capital's